FGFR1 and cancer: In summary, we propose the following mode of action for FGF2 dual warhead conjugate: The conjugate recognizes elevated levels of FGFR1 on the surface of cancer cells and utilizing receptor-mediated endocytosis it is targeted into lysosomes, degraded releasing α-amanitin and MMAE.